Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Chauvie, S.
73  Ergebnisse:
Personensuche X
?
1

18F FLUORINE PET TRACER DIFFERENT BIODISTRIBUTIONS CAN LEAD..:

De Maggi, A. ; Bergesio, F. ; Murru, E....
Physica Medica.  115 (2023)  - p. 102954 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Baseline PET Total Metabolic Tumor Volume has a prognostic ..:

Skrypets, T. ; Chauvie, S. ; Manni, M....
Hematological Oncology.  41 (2023)  S2 - p. 349-349 , 2023
Link: https://doi.org/10.1002/..
 
?
3

The impact of spleen metabolic tumor volume on total metabo..:

Guerra, L. ; Chauvie, S. ; Marcheselli, L....
Hematological Oncology.  41 (2023)  S2 - p. 339-340 , 2023
Link: https://doi.org/10.1002/..
 
?
4

CLINICAL TRIAL QUALIFICATION OF PET-CT SCANNERS IN ONCO-HAE..:

Bergesio, F. ; De Maggi, A. ; Murru, E...
Physica Medica.  115 (2023)  - p. 102836 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Clinical utility of circulating tumor DNA qualification and..:

Pirosa, M. C. ; Bruscaggin, A. ; Terzi di Bergamo, L....
Hematological Oncology.  41 (2023)  S2 - p. 319-321 , 2023
Link: https://doi.org/10.1002/..
 
?
6

SP-0029 The role of medical physicists in clinical trials a..:

Abbott, N.L. ; Appelt, A. ; Chauvie, S....
Radiotherapy and Oncology.  182 (2023)  - p. S8-S9 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Lessons Learned from the SkinScan Project:

, In: 2023 IEEE Nuclear Science Symposium, Medical Imaging Conference and International Symposium on Room-Temperature Semiconductor Detectors (NSS MIC RTSD),
Pia, M. G. ; Boccacci, P. ; Chauvie, S.... - p. 1-1 , 2023
Link: https://doi.org/10.1109/..
 
?
8

THE SFM: CENTRAL ROLE IN THE PROCEDURE FOR MRI EXAMINATIONS..:

Murru, E. ; De Maggi, A. ; Bergesio, F....
Physica Medica.  115 (2023)  - p. 103051 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Baseline‐PET derived metrics are the most relevant factors ..:

Zaucha, J. M. ; Picardi, M. ; Kurlapski, M....
Hematological Oncology.  41 (2023)  S2 - p. 350-351 , 2023
Link: https://doi.org/10.1002/..
 
?
10

COMBINED USE OF MINIMAL RESIDUAL DISEASE MONITORING AND FDG..:

Ferrero, S. ; Assanto, G. M. ; Durmo, R....
Hematological Oncology.  41 (2023)  S2 - p. 183-185 , 2023
Link: https://doi.org/10.1002/..
 
?
11

Prognostic value of the end of induction PET in patients wi..:

Guerra, L. ; Bergesio, F. ; Fallanca, F....
Hematological Oncology.  41 (2023)  S2 - p. 378-378 , 2023
Link: https://doi.org/10.1002/..
 
?
12

S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BA..:

Pirosa, M. C. ; Bruscaggin, A. ; Terzi di Bergamo, L....
HemaSphere.  6 (2022)  - p. 126-127 , 2022
Link: https://doi.org/10.1097/..
 
?
13

RADIATION FREE THERAPY OR THE INITIAL TREATMENT OF GOOD PRO..:

Gallamini, A. ; Walewski, J. ; Rambaldi, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
14

Intraoperative uterine iliac artery embolization in planned..:

Roberto, E. ; De Maggi, A. ; Dalmasso, F....
Physica Medica.  92 (2021)  - p. S234-S235 , 2021
Link: https://doi.org/10.1016/..
 
?
15

CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC ..:

Spina, V. ; Pirosa, M. C. ; Bruscaggin, A....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
1-15